Ra Medical Systems Inc (RMED) |
|
0.2573 0.024 (10.05%)
|
09-27 21:57 |
|
Open: |
0.22 |
Pre. Close: |
0.2338 |
|
High:
|
0.2614 |
Low:
|
0.22 |
|
Volume:
|
4,475,015 |
Market Cap:
|
19M |
|
|
|
|
Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company is headquartered in Carlsbad, California and currently employs 99 full-time employees. The firm is focused on commercializing excimer lasers for use in the treatment of dermatological and vascular diseases. The company develops, manufactures and markets medical devices targeting the dermatology and vascular specialties. The company operates through two segments: the vascular segment and the dermatology segment. The Company’s laser technology is used for the treatment of psoriasis, vitiligo, atopic dermatitis, leukoderma, and peripheral artery disease (PAD). Its Destruction of Arteriosclerotic Blockages by Laser Radiation Ablation (DABRA) is an excimer laser and disposable catheter system treatment of vascular blockages resulting from lower extremity vascular disease. Pharos is its excimer laser device that emits highly concentrated ultraviolet light and is used as a tool in the treatment of dermatological skin disorders. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.26 - 0.262 |
0.262 - 0.263 |
|
Low:
|
0.217 - 0.219 |
0.219 - 0.22 |
|
Close:
|
0.258 - 0.26 |
0.26 - 0.262 |
|
Technical analysis |
as of: 2020-09-25 4:34:18 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 0.38 One year: 0.46 |
| Support: |
Support1: 0.21 Support2: 0.18 |
| Resistance: |
Resistance1: 0.32 Resistance2: 0.39 |
| Pivot: |
0.25  |
| Moving Average: |
MA(5): 0.24 MA(20): 0.27
MA(100): 0.46 MA(250): 1.02 |
| MACD: |
MACD(12,26): -0.02 Signal(9): -0.03 |
| Stochastic oscillator: |
%K(14,3): 28.25 %D(3): 18.58 |
| RSI: |
RSI(14): 41.67 |
| 52-week: |
High: 2.69 Low: 0.21 Change(%): -81.6 |
| Average Vol(K): |
3-Month: 580362 10-Days: 241941 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.RMED has closed below upper band by 41.9%. Bollinger Bands are 80.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to RMED's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 25 Sep 2020
Recent Change of 7.01% in the Ra Medical Systems Inc. (RMED) market price might lead to pleasant surprises - The InvestChronicle
Fri, 25 Sep 2020
Ra Medical Systems, Inc. (NYSE:RMED) Projected to Grow by 334.78% Or More - Marketing Sentinel
Thu, 24 Sep 2020
The Rejuvenation of Ra Medical Systems Inc. (NYSE:RMED) - The Oracle Dispatch
Tue, 22 Sep 2020
Ra Medical Systems, Inc. (NYSE:RMED) surprises Wall Street with -2.24% stock price loss - Marketing Sentinel
Tue, 22 Sep 2020
Ra Medical Systems Inc. (RMED) Just Got Our Attention - The News Heater
Tue, 15 Sep 2020
Ra Medical Systems Inc. (RMED) is on the roll with an average volume of 5.85M in the recent 3 months - The InvestChronicle
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
72 |
| Shares Float (M) |
65 |
|
% Held by Insiders
|
44.27 |
|
% Held by Institutions
|
18.57 |
|
Shares Short (K)
|
2,660 |
|
Shares Short P. Month (K)
|
3,470 |
Stock Financials |
|
EPS
|
-2.799 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.710 |
|
Profit Margin
|
|
|
Operating Margin
|
-813.60 |
|
Return on Assets (ttm)
|
-54.9 |
|
Return on Equity (ttm)
|
-114.1 |
|
Qtrly Rev. Growth
|
-58.2 |
|
Gross Profit (p.s.)
|
-0.023 |
|
Sales Per Share
|
0.077 |
|
EBITDA (p.s.)
|
-0.601 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-30 |
|
Levered Free Cash Flow (M)
|
-14 |
Stock Valuations |
|
PE Ratio
|
-0.09 |
|
PEG Ratio
|
|
|
Price to Book value
|
0.36 |
|
Price to Sales
|
3.35 |
|
Price to Cash Flow
|
-0.62 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
